Skip to main content

ORIGINAL RESEARCH article

Front. Cell Dev. Biol. , 05 February 2021

Sec. Cell Death and Survival

Volume 8 - 2020 | https://doi.org/10.3389/fcell.2020.610097

This article is part of the Research Topic Dynamical Networks of Life/Death Decisions in a Cell: From DNA Repair to Cell Death View all 19 articles

RETRACTED: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

Retracted

A retraction of this article was approved in:

  1. Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

    1. Read retraction
\r\nLi-Mei Wu&#x;Li-Mei Wu1†Xiao-Zhong Liao&#x;Xiao-Zhong Liao2†Yan Zhang&#x;Yan Zhang1†Zi-Rui HeZi-Rui He1Shi-Qing NieShi-Qing Nie1Bin KeBin Ke3Lin ShiLin Shi4Jian-Fu Zhao Jian-Fu Zhao1*Wen-Hui Chen Wen-Hui Chen1*
  • 1Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China
  • 2Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
  • 3Department of Traditional Chinese Medicine, Cancer Center of Sun Yat-sen University, Guangzhou, China
  • 4Department of Traditional Chinese Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Wu L-M, Liao X-Z, Zhang Y, He Z-R, Nie S-Q, Ke B, Shi L, Zhao J-F and Chen W-H (2021) Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway. Front. Cell Dev. Biol. 8:610097. doi: 10.3389/fcell.2020.610097

Received: 25 September 2020; Accepted: 30 November 2020;
Published: 05 February 2021; Retracted: 05 May 2021.

Edited by:

Inna N. Lavrik, University Hospital Magdeburg, Germany

Reviewed by:

Jiaxing Zhang, Sun Yat-sen University, China
Mario Cioce, Campus Bio-Medico University, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

95% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more